Ocular Therapeutix EPS Diluted from Extraordinaries (Quarterly) Insights

Ocular Therapeutix, Inc. (OCUL)

7.78 +0.75 (+10.67%) USD | NASDAQ | Feb 20, 16:00

7.68 -0.10 (-1.29%) After-Hours: 20:00

View EPS Diluted from Extraordinaries (Quarterly) for OCUL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Extraordinaries (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Extraordinaries (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Extraordinaries (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	--
Boston Scientific Corp.	--
Alnylam Pharmaceuticals, Inc.	--
EyePoint Plc	--
Vertex Pharmaceuticals, Inc.	--